Using MMP-2/9 antibodies and ERK inhibitor PD98059, we validate that Derlin-1 induces bladder cancer invasion through activation of ERK signaling, which in turn upregulates MMP-2 and MMP-9 protein expression. This evidence concerns the gene DERL1 and urinary bladder cancer.